News
Satellite Healthcare and Modulim Announce Strategic Partnership
Irvine, CA—July 12, 2022— Modulim, a health technology company that delivers point-of-care microvascular and data insights to save limbs and improve lives, announces a strategic
Modulim Announces Intent to Drive Value-Based Care in Nephrology Market With Custom Limb Preservation Solution
Irvine, CA—July 6, 2022— Modulim, a health technology company that delivers point-of-care microvascular and data insights to save limbs and improve lives, announced today that
Modulim Featured in Article About Innovation on Main Page of UCI Website
Irvine, CA—July 2021 The UCI Beall Applied Innovation Center recognized Modulim CTO and Founder David Cuccia in a recent article on successful startups. Learn more
Modulim to Present at LSI Emerging MedTech Summit
Irvine, CA—May 12, 2021 Modulim’s CEO, Charlie Huiner, will be presenting at this year’s LSI 2021 Emerging Medtech Summit in Dana Point, CA May 11th-13th 2021.
Case study shows how SFDI measures vascular steal in a post-surgical diabetic foot flap
Irvine, CA—April 1, 2021 Tissue flaps are commonly used in limb salvage to heal wounds and prevent amputations. Patients with advanced peripheral arterial disease (PAD),
Clinical publication reports that SFDI measures dermal microcirculatory changes prior to ulcer formation
Irvine, CA—March 8, 2021 In a recent case series published in the BMJ Open Diabetes Research & Care journal, a clinical research team lead by
Modulim Announces SFDI Technology’s Potential Limb Saving Applications in Research Conducted with Kaiser Permanente
Irvine, CA—February 1, 2021 Modulim, the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, announced today the results
Modulim featured as Showcase company by National Institute of Aging
Modulated Imaging (dba Modulim) was recently highlighted by National Institute of Aging (NIA) as a showcase company. Modulim successfully completed a Phase 2 Small Business Innovation Research
MODULIM TO PRESENT AT DIGITAL MEDICINE & MEDTECH SHOWCASE 2021
Irvine, CA–January 11-15, 2021 Modulim is participating in Digital Medicine & Medtech Showcase 2021, part of Biotech Showcase™ 2021, and providing an on-demand company presentation.
Modulim Announces CE Mark of Clarifi® Imaging System for Microvascular Assessment
Irvine, CA—December 2, 2020 Modulim, the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, announced today that Clarifi® has received
Modulim Supports Development of Optical Technologies for Soldiers on the Battlefield
July 1, 2020 Check out this article detailing research using optical technologies to help manage soldiers health on battlefield. We are grateful to partner with the Beckman
Modulim Expands Advisory Board
June 29, 2020 Modulim, the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, announced that Dr. Anand Patel,
Spatial Frequency Domain Imaging (SFDI) Revenue Cycle Processes
February 3, 2020 Modulim’s new proprietary CPT code 0061U was highlighted by Kathleen Schaum, in Today’s Wound Clinic. The code can be used for capturing five
Modulim Granted CPT Code from the American Medical Association for its Noninvasive Microvascular Assessment Technology
Irvine, CA — July 30, 2019 (BUSINESS WIRE) — Modulim, the global leader in noninvasive microvascular assessment using spatial frequency domain imaging (SFDI), has announced that
Journal of Biomedical Optics Modulim’s Founder and VP of R&D Guest Editors for Special Section on SFDI Technology
July 2019 The Journal of Biomedical Optics recently featured a special section on Spatial Frequency Domain Imaging (SFDI). Our founder & CTO, David Cuccia, and our VP
Modulim’s Poster at the International Symposium on the Diabetic Foot Highlighted Microcirculation Measurements of Subjects in Ulcer Remission
The 8th International Symposium on the Diabetic Foot (ISDF), held every four years, took place last week from May 22-25 at The Hague in the Netherlands. As
New Study Finds SFDI a Promising Technology for Assessing Patients At-Risk of PAD
IRVINE, Calif.–April 23, 2019 – (BUSINESS WIRE)– Modulim, a recognized leader in SFDI-based optical imaging solutions for the non-invasive assessment of tissue health, has announced the findings
FDA Clearance Received for New Clarifi Imaging System
IIrvine, CA — July 31, 2018 — Modulated Imaging, the leader in optical imaging solutions powered by Spatial Frequency Domain Imaging (SFDI) for non-invasive assessment
ISO 13485 Certification Awarded to Modulated Imaging
IRVINE, CA – May 1, 2018 Modulated Imaging, the leader in optical imaging solutions powered by Spatial Frequency Domain Imaging (SFDI) for noninvasive assessment of
FDA Clearance Received for Ox-Imager CS System
Irvine, CA – January 18, 2017 Modulated Imaging, Inc. announced today that it has received clearance from the FDA for its Ox-Imager CS technology. This
Modulated Imaging Wins 2016 Medical Device Innovation Award
Irvine, CA—October 28, 2016 Modulated Imaging received the Orange County (OC) Tech Alliance 2016 Medical Device Innovation Award at the 23rd Annual OC Tech Alliance Award
Modulated Imaging Awarded $1.8 Million NIH Grant
Irvine, CA—August 04, 2016 Modulated Imaging announced today that they have been awarded a $1.8 million SBIR Phase II grant by the National Institutes of
US Patent Covers Important Updates to Advances in SFDI Technology
November 18, 2014 Modulated Imaging learned today that the United States Patent and Trademark Office has issued US Patent 8,892,192 covering important updates to the
Amaan Mazhar Receives Alumni of the Year Award
October 31, 2014 Rice University’s Department of Bioengineering announced that Amaan Mazhar, Ph.D. was one of three recipients of its Alumni of the Year Award.
Modulated Imaging Issued US Patent for SFDI
August 13, 2013 Today, Modulated Imaging is proud to announce that the United States Patent and Trademark Office has issued US Patent 8,509,879 covering apparatus
Phase II Grant Awarded to Modulated Imaging
June 5, 2013 Modulated Imaging is excited to share that we have been awarded a Small Business Innovation Research Phase II Grant (9R44AR064657) from the
Modulated Imaging Awarded Burn Depth Analysis Grant
September 24, 2012 This week, Modulated Imaging was awarded a Small Business Innovation Research Phase II Grant (W81XWH-11-C-108) from the US Army Medical Research, part
David Cuccia Announced as ASLMS’s 2012 Grant Recipient
The American Society For Laser Medicine & Surgery (ASLMS) announced today that Modulated Imaging co-founder and CEO David Cuccia, Ph.D., has been awarded the 2012
A $1.3 Million Phase II Grant Awarded to Modulated Imaging
September 15, 2011 Modulated Imaging is proud to announce that we have been awarded a Small Business Technology Transfer Phase II Grant (2R42GM077713) from the